Health Care

INSYS Therapeutics’ (NASDAQ:INSY) founder Dr. John N. Kapoor resigned from his role with the company’s board in the wake of being charged with participating in a nationwide opioid bribery and kickback scheme.

Swiss drugmaker Novartis on Monday offered to buy France's Advanced Accelerator Applications in a $3.9 billion cash deal to strengthen the oncology portfolio at the world's biggest maker of prescription medicines.

Officials of Japan's ministry of land and transport conducted on-site checks Monday at two factories of the automaker Subaru where unqualified workers were inspecting its cars, as reports said the company plans to recall 255,000 vehicles to be re-inspected.

General Motors has agreed to a $13.9 million settlement with Orange County, California, after prosecutors accused the auto giant of concealing serious safety defects to avoid costly recalls and part replacements.

A CVS-Aetna combination could create a health colossus that can reach deeper into the average customer's life to manage care and cut costs, according to analysts who follow the companies.

Technology companies are jumping Friday morning as investors applaud third-quarter reports from big names including Microsoft, Intel, and Alphabet, Google's parent company.

More than 60,000 infant motion seats are being recalled because the motor can overheat, posing a fire hazard.

Merck & Co. is reporting a third-quarter loss of $56 million after a profit in the same period a year earlier, but it still beat Wall Street expectations.

Merck & Co on Friday reported a quarterly profit that beat analysts' estimates, benefiting from sales of its immuno-oncology drug Keytruda.

Japanese automaker Subaru is investigating whether it carried out illegal inspections on its own vehicles and if any recalls might be needed.

U.S. stocks are edging higher Thursday morning as technology companies and banks advance.

Amazon executives remained mum Thursday on rumors that the e-commerce giant is taking steps to become a wholesale distributor of pharmaceuticals.

Amazon.com has struck again. Only this time the internet giant is shaking up an industry it hasn't yet entered.

A blockbuster pharma-health insurance deal is said to be in the works.

The latest on developments in financial markets (All times local): Stocks are opening higher on Wall Street led by technology companies and banks as the market regains most of the previous day's losses.

PHOENIX (AP) — U.S. prosecutors brought a fraud and racketeering case Thursday against the founder of an opioid medication maker, Insys Therapeutics (NASDAQ:INSY), that has faced increasing scrutiny from authorities across the country over allegations of pushing prescriptions of powerful painkillers amid a drug epidemic that is claiming thousands of lives each year.

General Electric Co is exploring divesting its transportation and health care information technology businesses, as it seeks to reshape its portfolio under new Chief Executive John Flannery, people familiar with the matter said.

As the White House gets ready to declare the opioid epidemic a public health emergency on Thursday, pharmacies are taking matters into their own hands, stocking an FDA-approved drug that can reverse the effects of an opioid overdose.